药明康德(02359)今日盘中大涨5%,引起了市场的广泛关注。
主要原因是药明康德集团通过两次大宗交易,累计出售药明合联7.17%的股权,折合8600万股,累计成交金额约24.26亿港元,相当于人民币20.16亿元。这笔交易使公司获得了可观的投资收益,占最近一期经审计净利润的10%以上。
药明康德表示,出售股票所得现金收益将用于加速推进全球产能建设、吸引人才、强化一体化CRDMO业务模式,以满足全球客户和患者日益增长的需求。市场对此反应积极,体现了投资者对公司长期发展前景的信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.